Completed OBSERVATIONAL NCT00364624

Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Adrenal Cortical Function in Patients With Newly Diagnosed Lung Cancer

Sponsor: Princess Margaret Hospital, Hong Kong

Conditions Adrenal Insufficiency Lung Cancer

Updated 6 times since 2017 Last updated: Jan 15, 2009 Started: Aug 31, 2006 Primary completion: Apr 30, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Adrenal Insufficiency and Lung Cancer, this trial is completed. The trial is conducted by Princess Margaret Hospital, Hong Kong and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Princess Margaret Hospital, Hong Kong

Data source: Princess Margaret Hospital, Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kowloon, China